首页> 外文期刊>The Journal of Urology >Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
【24h】

Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?

机译:化学疗法后切除的半实体元件是否伴有较高的急性发病率?

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: A seminomatous element in patients undergoing retroperitoneal lymph node dissection for testicular cancer is associated with a desmoplastic reaction that renders retroperitoneal surgery more challenging. We examined the impact of seminomatous elements on the rate of complications and the need for additional intraoperative procedures in patients undergoing post-chemotherapy retroperitoneal lymph node dissection. MATERIALS AND METHODS: The testis cancer data base at our institution was retrospectively reviewed and 1,366 patients were identified who underwent post-chemotherapy retroperitoneal lymph node dissection between 1973 and 2001. In 97 patients there was an element of seminoma in the dissection specimen and/or pure seminoma in the testicular primary specimen (seminoma group). The remaining 1,269 patients underwent post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testicular tumors. The rates of intraoperative complications and additional procedures as well as postoperative complications were analyzed. RESULTS: Of the 97 patients in the seminoma group 37 (38.1%) required a total of 47 additional intraoperative procedures, including 25 nephrectomies, 9 inferior vena caval resections, 5 arterial grafts, 5 bowel resections and 3 hepatic resections/biopsies, compared with 340 of the 1,269 patients (26.8%) in the group without seminomatous elements (p = 0.02). Postoperatively complications occurred in 24 of 97 patients (24.7%) in the seminoma group versus 257 of 1,269 (20.3%) in the group without seminomatous elements (p = 0.29). One of the 97 patients in the seminoma group died secondary to postoperative complications. CONCLUSIONS: A seminomatous element in patients undergoing post-chemotherapy retroperitoneal lymph node dissection is associated with a higher rate of additional intraoperative procedures and postoperative complications than in patients without seminomatous elements. However, resection is still possible with acceptable morbidity when indicated in appropriately selected patients.
机译:目的:进行睾丸癌后腹膜后淋巴结清扫术的患者中的半自然因素与去塑反应有关,使腹膜后手术更具挑战性。我们检查了化疗后腹膜后淋巴结清扫术患者中半自然因素对并发症发生率的影响以及是否需要额外的术中操作。材料与方法:回顾性回顾了我们机构的睾丸癌数据库,确定了1973年至2001年间接受腹膜后淋巴结清扫术后化疗的1,366例患者。在97例患者中,解剖标本和/或中存在精原细胞瘤睾丸原发性标本中的单纯精原细胞瘤(血清肿组)。其余1,269例因非精原细胞睾丸肿瘤接受化疗后腹膜后淋巴结清扫术。分析了术中并发症发生率,附加手术以及术后并发症发生率。结果:精原细胞瘤组中的97例患者中,有37例(38.1%)需要额外的47例术中手术,包括25例肾切除术,9例下腔静脉切除术,5例动脉移植,5例肠切除术和3例肝切除/活检。 1 269例患者中有340例(26.8%)没有半致盲因素(p = 0.02)。精原细胞瘤组中有97例患者中有24例发生了术后并发症(24.7%),而无半精原细胞组的1269例中有257例(20.3%)(p = 0.29)。精原细胞瘤组的97例患者中有1例死于术后并发症。结论:接受化学疗法后腹膜后淋巴结清扫术的患者中,半精原位要素比无半精原位要素的患者术中手术和术后并发症发生率更高。但是,如果在适当选择的患者中进行手术,则切除仍可能具有可接受的发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号